166 related articles for article (PubMed ID: 16336322)
1. Side-effects of treatments for locally advanced prostate cancer.
O'Connor KM; Fitzpatrick JM
BJU Int; 2006 Jan; 97(1):22-8. PubMed ID: 16336322
[No Abstract] [Full Text] [Related]
2. No long-term effects of hormonal therapy preceding brachytherapy on urinary function and health-related quality of life among prostate cancer patients.
Evers J; Kupper N; Kessing D; Davits R; Engelen A; Poortmans P; Mols F
Urology; 2010 Nov; 76(5):1150-6. PubMed ID: 20869105
[TBL] [Abstract][Full Text] [Related]
3. Side-effects of treatments for locally advanced prostate cancer.
Gardiner RF; Nicol DL; Green HJ; Pakenham KI
BJU Int; 2006 Jul; 98(1):229-30. PubMed ID: 16831173
[No Abstract] [Full Text] [Related]
4. Interstitial pneumonitis following bicalutamide treatment for prostate cancer.
McCaffrey JA; Scher HI
J Urol; 1998 Jul; 160(1):131. PubMed ID: 9628626
[No Abstract] [Full Text] [Related]
5. Prostate cancer tissue is masked by bicalutamide: a case report.
Ellinger J; Bastian PJ; Biermann K; Schmidt ME; Textor J; Bollmann D; Zhou H; Müller SC
Eur J Med Res; 2007 May; 12(5):212-5. PubMed ID: 17513193
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and management of erectile dysfunction after various treatments for prostate cancer.
Soh J; Kaiho Y; Kikuchi E; Oya M; Yoshioka K; Nakagami Y; Hatano T; Ozu C; Horiguchi Y; Namiki K; Tachibana M; Hisasue S; Tanaka N; Asakawa I
Int J Urol; 2010 Aug; 17(8):689-97. PubMed ID: 20590940
[No Abstract] [Full Text] [Related]
7. [Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
Abdah-Bortnyak R; Bernstein Z; Ramon N; Zalman D; Shnaider J; Kuten A
Harefuah; 2007 Feb; 146(2):126-8, 164-5. PubMed ID: 17352282
[TBL] [Abstract][Full Text] [Related]
8. Treatment of clinically organ confined prostate cancer.
McLeod DG
Scand J Urol Nephrol Suppl; 1999; 203():35-9. PubMed ID: 10636568
[No Abstract] [Full Text] [Related]
9. Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment.
Michalopoulos NV; Keshtgar MR
N Engl J Med; 2012 Oct; 367(15):1449. PubMed ID: 23050528
[No Abstract] [Full Text] [Related]
10. [Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness].
Kaprin AD; Kostin AA; Tsybul'skiĭ AD
Vopr Onkol; 2009; 55(3):285-90. PubMed ID: 19670727
[No Abstract] [Full Text] [Related]
11. The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer.
Iversen P; Roder MA
Expert Rev Anticancer Ther; 2008 Mar; 8(3):361-9. PubMed ID: 18366284
[TBL] [Abstract][Full Text] [Related]
12. Treatment of bicalutamide-induced breast events.
Sieber PR
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1773-9. PubMed ID: 18062751
[TBL] [Abstract][Full Text] [Related]
13. A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
Chianakwalam CI; McCahy P; Griffiths NJ
Breast; 2005 Apr; 14(2):163-4. PubMed ID: 15767188
[No Abstract] [Full Text] [Related]
14. The bicalutamide 150 mg early prostate cancer program: findings of the North American trial at 7.7-year median followup.
McLeod DG; See WA; Klimberg I; Gleason D; Chodak G; Montie J; Bernstein G; Morris C; Armstrong J
J Urol; 2006 Jul; 176(1):75-80. PubMed ID: 16753373
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment.
Shepard DR
Urology; 2010 May; 75(5):1137. PubMed ID: 20451735
[No Abstract] [Full Text] [Related]
16. Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?
Parker WR; Montgomery JS; Wood DP
Curr Opin Urol; 2009 May; 19(3):303-8. PubMed ID: 19300266
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant hormone therapy with casodex in a dose 150 mg prior to radical prostatectomy in patients with prostatic cancer].
Rusakov IG; Petrov SB; Alekseev BIa; Veliev EI
Urologiia; 2004; (4):15-9. PubMed ID: 15457946
[No Abstract] [Full Text] [Related]
18. Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Van Poppel H
Eur Urol; 2007 Jul; 52(1):115. PubMed ID: 17270341
[No Abstract] [Full Text] [Related]
19. Bicalutamide.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17458049
[TBL] [Abstract][Full Text] [Related]
20. Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity.
Petit JH; Gluck C; Kiger WS; Henry DL; Karasiewicz C; Talcott J; Berg S; Holupka E; Kaplan I
Urol Oncol; 2008; 26(4):372-7. PubMed ID: 18367113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
